Literature DB >> 582279

On the origin and significance of neuromelanin.

D G Graham.   

Abstract

The amount of cytoplasm within catecholamine neurons occupied by neuromelanin was found to increase progressively with the patient's age. The accretion of neuromelanin was accompanied by an expansion of the cytoplasm of neurons in the substantia nigra and locus ceruleus. These observations support the concept that neuromelanin is a waste product of catecholamine metabolism, derived from the oxidation of dopamine, nonrepinephrine, and related compounds to quinones. The existence of oxidative pathways for catecholamines suggests that defects in their compartmentalization, transport, or degradation may present the cell with sufficient levels of cytotoxic quinones and free radical species to result in the degeneration of neurons observed in Parkinson's disease.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 582279

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  29 in total

1.  Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.

Authors:  Keita Kuya; Yuki Shinohara; Fuminori Miyoshi; Shinya Fujii; Yoshio Tanabe; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2016-01-16       Impact factor: 2.804

Review 2.  Current theories on the cause of Parkinson's disease.

Authors:  J W Langston
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

3.  Neuromelanin and iron in human locus coeruleus and substantia nigra during aging: consequences for neuronal vulnerability.

Authors:  F A Zucca; C Bellei; S Giannelli; M R Terreni; M Gallorini; E Rizzio; G Pezzoli; A Albertini; L Zecca
Journal:  J Neural Transm (Vienna)       Date:  2006-04-28       Impact factor: 3.575

4.  The surface oxidation potential of human neuromelanin reveals a spherical architecture with a pheomelanin core and a eumelanin surface.

Authors:  William D Bush; Jacob Garguilo; Fabio A Zucca; Alberto Albertini; Luigi Zecca; Glenn S Edwards; Robert J Nemanich; John D Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2006-09-25       Impact factor: 11.205

Review 5.  Neuromelanin of the human substantia nigra: an update.

Authors:  Fabio A Zucca; Emy Basso; Francesca A Cupaioli; Emanuele Ferrari; David Sulzer; Luigi Casella; Luigi Zecca
Journal:  Neurotox Res       Date:  2013-10-24       Impact factor: 3.911

6.  Ultrastructural evidence for glutamatergic dysregulation in schizophrenia.

Authors:  Rosalinda C Roberts; Lesley A McCollum; Kirsten E Schoonover; Samuel J Mabry; Joy K Roche; Adrienne C Lahti
Journal:  Schizophr Res       Date:  2020-01-31       Impact factor: 4.939

7.  Neural differentiation in the OTT-6050 mouse teratoma: enzymatic and immunofluorescence characterization of a tumor fraction showing melanogenesis in neuroepithelial cells.

Authors:  E Erdelyi; S R VandenBerg; J Raese; J D Barchas; L J Rubinstein; M M Herman
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

8.  Model neuromelanins as antioxidative agents during lipid peroxidation.

Authors:  T Wilczok; K Stepien; A Dzierzega-Lecznar; A Zajdel; A Wilczok
Journal:  Neurotox Res       Date:  1999-12       Impact factor: 3.911

9.  Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies.

Authors:  Shinichiro Kitao; Eiji Matsusue; Shinya Fujii; Fuminori Miyoshi; Toshio Kaminou; Shinsuke Kato; Hisao Ito; Toshihide Ogawa
Journal:  Neuroradiology       Date:  2013-05-15       Impact factor: 2.804

10.  Three-dimensional computer reconstruction of midbrain dopaminergic neuronal populations: from mouse to man.

Authors:  D C German; D S Schlusselberg; D J Woodward
Journal:  J Neural Transm       Date:  1983       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.